Ultrasound of optic nerve in multiple sclerosis transition
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study uses ultrasound to measure the optic nerve in people with relapsing-remitting multiple sclerosis who have never had optic neuritis. It aims to see if this measurement can predict when the disease might change from one form to another.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 50 years old
- You have relapsing-remitting multiple sclerosis (RRMS)
- You have never had optic neuritis (inflammation of the optic nerve)
- You do not have other eye problems like diabetes or high blood pressure
- You have not been on fingolimod (Gilenya) for 6 months or more
- You have not had a relapse or used steroids in the past 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how fast and how accurately your eyes process visual information and how eye movements look in people with multiple sclerosis. It may help researchers understand vision-related effects of MS using objective eye measurements.
This study measures how blood flow in the eye changes in people with relapsing-remitting multiple sclerosis (RRMS) who previously had optic neuritis. The goal is to understand eye/brain blood-flow signals and how they may relate to MS.
This study uses a special eye scan (OCT-A) and a vision test (perimetry) to see how MS affects the eyes over time. It may help doctors better understand and monitor MS-related eye damage.
This study looks at how early damage to the optic nerve (the nerve that connects your eye to your brain) might predict future multiple sclerosis (MS) in people who have just had their first neurological symptoms (called a clinically isolated syndrome). You will have an MRI of your eyes and a special eye scan to see if these tests can help doctors know who is more likely to develop MS.
This study uses advanced eye scans (OCT and retinal vessel imaging) to look for patterns in the retina that might be different in people with Multiple Sclerosis and other neuroinflammatory diseases. The goal is to find markers that could help doctors better understand and monitor these conditions.
This study looks at why some people with relapsing-remitting multiple sclerosis (RRMS) get worse even when they don't have relapses. It uses eye scans and other tests to find early signs of progression, which could help tailor treatments.
Hear when a new Relapsing Remitting Multiple Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.